All participants provided written informed consent. The study was approved by the Institutional Review Board of the Saitama Medical Center, Jichi Medical University, Japan (RIN 15–104).
1. Device for the monitoring of rSO2
2. Attaching the measurement sensor
3. Puncturing the dialysis shunt and starting monitoring
Cerebral rSO2 values before HD were lower than those in healthy subjects and cerebral rSO2 in HD patients with diabetes mellitus (DM) were lower than those in HD patients without DM (Figure 1)16. Furthermore, although tissue oxygenation continues without a decrease of BP during HD, we incidentally observed changes in cerebral and hepatic rSO2 due to intradialytic hypotension (Figure 2). Due to the continuous monitoring, the changes in tissue oxygenation were observed more quickly than by intermittently monitored BP. Data were expressed as means ± standard error. The analysis of variance for non-paired values was used to compare three groups.
Figure 1: Comparison of cerebral rSO2 before HD among HD patients with diabetes mellitus (n = 27), HD patients without diabetes mellitus (n = 27) and healthy subjects (n = 28). The patients included 38 men and 16 women with mean age of 67.7 ± 1.2 years and HD duration of 6.5 ± 1.9 years. The causes of chronic kidney disease were DM (27 patients), chronic glomerulonephritis (14 patients), nephrosclerosis (4 patients), polycystic kidney disease (4 patients), and other (5 patients). The error bars indicate the standard error. The data were based on and the figure has been modified from a previous report16. DM; diabetes mellitus, HD; hemodialysis, rSO2; regional oxygen saturation. Please click here to view a larger version of this figure.
Figure 2: Changes in cerebral and hepatic rSO2 in a patient with acute intradialytic hypotension. BP; blood pressure, hr; hour, rSO2; regional oxygen saturation, UFR; ultrafiltration rate. Please click here to view a larger version of this figure.
DBB-100NX | Nikkiso | DBB-100NX | Dialysis machine |
INVOS 5100c | Covidien Japan | INVOSTM 5100c | tissue oxygenation device |
SOMASENSER | Covidien Japan | CV-SAFB-SM/INTL | NIRS sensor |
Near-infrared spectroscopy (NIRS) has recently been applied as a tool to measure regional oxygen saturation (rSO2), a marker of tissue oxygenation, in clinical settings including cardiovascular and brain surgery, neonatal monitoring and prehospital medicine. The NIRS monitoring devices are real-time and noninvasive, and have mainly been used for evaluating cerebral oxygenation in critically ill patients during an operation or intensive care. Thus far, the use of NIRS monitoring in patients with chronic kidney disease (CKD) including hemodialysis (HD) has been limited; therefore, we investigated rSO2 values in some organs during HD. We monitored rSO2 values using a NIRS device transmitting near-infrared light at 2 wavelengths of attachment. The HD patients were placed in a supine position, with rSO2 measurement sensors attached to the foreheads, the right hypochondrium and the lower legs to evaluate rSO2 in the brain, liver and lower leg muscles, respectively. NIRS monitoring could be a new approach to clarify changes in organ oxygenation during HD or factors affecting tissue oxygenation in CKD patients. This article describes a protocol to measure tissue oxygenation represented by rSO2 as applied in HD patients.
Near-infrared spectroscopy (NIRS) has recently been applied as a tool to measure regional oxygen saturation (rSO2), a marker of tissue oxygenation, in clinical settings including cardiovascular and brain surgery, neonatal monitoring and prehospital medicine. The NIRS monitoring devices are real-time and noninvasive, and have mainly been used for evaluating cerebral oxygenation in critically ill patients during an operation or intensive care. Thus far, the use of NIRS monitoring in patients with chronic kidney disease (CKD) including hemodialysis (HD) has been limited; therefore, we investigated rSO2 values in some organs during HD. We monitored rSO2 values using a NIRS device transmitting near-infrared light at 2 wavelengths of attachment. The HD patients were placed in a supine position, with rSO2 measurement sensors attached to the foreheads, the right hypochondrium and the lower legs to evaluate rSO2 in the brain, liver and lower leg muscles, respectively. NIRS monitoring could be a new approach to clarify changes in organ oxygenation during HD or factors affecting tissue oxygenation in CKD patients. This article describes a protocol to measure tissue oxygenation represented by rSO2 as applied in HD patients.
Near-infrared spectroscopy (NIRS) has recently been applied as a tool to measure regional oxygen saturation (rSO2), a marker of tissue oxygenation, in clinical settings including cardiovascular and brain surgery, neonatal monitoring and prehospital medicine. The NIRS monitoring devices are real-time and noninvasive, and have mainly been used for evaluating cerebral oxygenation in critically ill patients during an operation or intensive care. Thus far, the use of NIRS monitoring in patients with chronic kidney disease (CKD) including hemodialysis (HD) has been limited; therefore, we investigated rSO2 values in some organs during HD. We monitored rSO2 values using a NIRS device transmitting near-infrared light at 2 wavelengths of attachment. The HD patients were placed in a supine position, with rSO2 measurement sensors attached to the foreheads, the right hypochondrium and the lower legs to evaluate rSO2 in the brain, liver and lower leg muscles, respectively. NIRS monitoring could be a new approach to clarify changes in organ oxygenation during HD or factors affecting tissue oxygenation in CKD patients. This article describes a protocol to measure tissue oxygenation represented by rSO2 as applied in HD patients.